Menu Search
Equities

Mantex AB

2NA:FRA

Mantex AB

Actions
  • Price (EUR)0.0026
  • Today's Change-0.001 / -27.78%
  • Shares traded12.00k
  • 1 Year change-80.94%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 07:05 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Mantex AB is a Sweden-based company that is engaged in development, production and sale of equipment for rapid and non-destructive material analysis of organic material by the use of X-rays of several energies. The products apply to biomass, including wood, wood chips, agricultural products and residues and are used in industrial processes for the determination of the dry content or energy content in materials within such industries as paper, bioenergy, process and food. The Company offers the following products: Biofuel Analyzer, which assesses the quality of wood-based biofuels; Flow Scanner, which applies to wood chips for pulp and paper production; and Log Scanner, which is used for foreign object detection and log measurements.

  • Revenue in SEK (TTM)7.47m
  • Net income in SEK-18.34m
  • Incorporated1998
  • Employees6.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.